Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 36 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 9644216

    Adeno-associated virus vectors for treatment of glycogen storage disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 9, 2017 · Expires May 4, 2037

    granted

  2. US 9644179

    Use of PDL1 expressing cells to convert T cells into regulatory T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 9, 2017 · Expires May 4, 2037

    granted

  3. US 9631192

    Auto-recognizing therapeutic RNA/DNA chimeric nanoparticles (NP)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  4. US 9629899

    Targeted cargo protein combination therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  5. US 9629897

    Methods of producing and using regulatory B-cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  6. US 9624475

    Genetically stable live attenuated respiratory syncytial virus vaccine and its production

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  7. US 9624306

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  8. US 9623020

    Thio compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  9. US 9616073

    Method for on-demand contraception

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  10. US 9617229

    Phenylmorpholines and analogues thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  11. US 9610338

    Serologic correlates of protection against bacillus anthracis infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  12. US 9605044

    Methods and compositions for modulating immune tolerance

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  13. US 9598471

    Bacteriocin with novel activity

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

  14. US 9598703

    Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

  15. US 9592207

    Intranasal administration of ketamine to treat depression

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  16. US 9593136

    Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  17. US 9579333

    Inhibition of HIV infection through chemoprophyalxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted

  18. US 9580492

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted

  19. US 9579302

    Ketone bodies to protect tissues from damage by ionizing radiation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted

  20. US 9566329

    Live, attenuated rubella vector to express vaccine antigens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  21. US 9567387

    T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  22. US 9562237

    Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted

  23. US 9556237

    Antiviral rift valley fever virus peptides and methods of use

    The United States of America, as represented by the Secretary of the Army, on behalf of the U.S. Army Medical Research Institute of Infectious Diseases · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  24. US 9556244

    Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.